POLYPEPTIDE-LIGAND FLT3 (VARIANTS), POLYNUCLEOTIDE (VARIANTS), EXPRESSING VECTOR (VARIANTS), STRAIN OF CELL CHO (VARIANTS), METHOD FOR PRODUCING POLYPEPTIDE-LIGAND FLT3 (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS) Russian patent published in 2004 - IPC

Abstract RU 2220979 C2

FIELD: molecular biology, biotechnology, pharmacy. SUBSTANCE: polynucleotide encoding polypeptide-ligand flt3 is cloned to expressing vector showing functionality in mammalian cells. Polypeptide-ligand flt3 is prepared by culturing the strain cell CHO transfected with vector. Pharmaceutical composition that is able to stimulate proliferation and differentiation of cell-precursors and stem cells contains polypeptide flt3 taken in the effective amount. Invention provides the development of agents used for treatment of patients with anemia, AIDS and cancer diseases. Invention can be used for preparing ligand flt3. EFFECT: improved preparing method, valuable biological and medicinal properties of polypeptide. 18 cl, 4 tbl, 14 ex

Similar patents RU2220979C2

Title Year Author Number
NEW CYTOKINE ZALPHA 11-LIGAND 2000
  • Novak Dzhulija Eh.
  • Presnell Skott R.
  • Spreker Sindi A.
  • Foster Donald K.
  • Kholli Richard D.
  • Gross Dzhejn A.
  • Dzhonston Dzhehnet V.
  • Nelson Ehndrju Dzh.
  • Dillon Stejsi R.
  • Khehmmond Andzhela K.
RU2258710C2
DNA SEQUENCE ENCODING POLYPEPTIDE THAT BINDS WITH MORT-1 (VARIANTS), POLYPEPTIDE (VARIANTS) AND METHOD FOR ITS PREPARING, VECTOR, METHOD FOR MODULATING LIGAND FAS-R OR TNF EFFECT ON CELLS (VARIANTS), METHOD FOR TREATMENT OF CELLS, METHOD FOR ISOLATION AND IDENTIFICATION OF PROTEINS, METHOD FOR MODULATING MORT-1-INDUCED EFFECT OR MORT-1-BINDING PROTEIN-INDUCED EFFECT ON CELLS 1996
  • Vollakh Dehvid
  • Boldin Mark
  • Goncharov Tanja
  • Gol'Tsev Jurij
RU2235779C2
LIGAND GITR AND MOLECULES AND ANTIBODIES BOUND WITH LIGAND GITR, AND VERSIONS OF THEIR APPLICATION 2004
  • Kollinz Mehri
  • Shevach Ehtan Menakhem
  • Makkh'Ju Rebekka S'Juzn
  • Uitters Mehtt'Ju Dzhejms
  • Jang Debora Ehnn
  • Birn Majkl Chehpmen
  • Reddi Padmalata F.
  • Stefenz Dzhoffri Lorens
  • Karreno Beatriz M.
RU2369636C2
ISOLATED SOLUBLE IL-20 RECEPTOR (VARIANTS) 2000
  • Foster Donald K.
  • Zu Venfeng
  • Mehdden Kehren L.
  • Kelli Dzhejms D.
  • Spreker Sindi A.
  • Brehndt Kehmeron S.
  • Rikson Mark U.
  • Presnell Skott R.
  • Foks Brajen A.
RU2279441C2
DNA MOLECULE ENCODING POLYPEPTIDE ABLE TO BIND WITH INTRACELLULAR DOMAIN OF FAS (FAS-IC) LIGAND RECEPTOR, POLYPEPTIDE, METHOD FOR ITS PREPARING, VECTOR, METHOD FOR MODULATION OF EFFECT OF FAS-R LIGAND ON CELLS (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS), METHOD FOR ISOLATION AND IDENTIFICATION OF PROTEIN 1995
  • Uollakh Dehvid
  • Boldin Mark
  • Varfolomeev Evgenij
  • Mett Igor'
RU2241747C2
NEW LIGAND OF CYTOKINE RECEPTOR ZCYTOR17 2003
  • Spresher Sindi A.
  • Kejper Jozef L.
  • Dasovich Marija M.
  • Grant Frehnsis Dzh.
  • Khehmmond Andzhela K.
  • Novak Dzhulija E.
  • Gross Dzhejn A.
  • Dillon Stejsi R.
RU2490276C2
METHOD AND SET FOR DETECTING GENE ENCODING MEMBRANE-BOUND PROTEIN, VECTOR (VARIANTS) 1999
  • Tsutija Masajuki
  • Saito Mikiesi
  • Okhtomo Tosikhiko
RU2246538C2
TRANSPOSASE POLYPEPTIDES AND USE THEREOF 2016
  • Belousova, Natalya
  • Cooper, Laurence, J.
RU2735700C2
POLYPEPTIDE POSSESSING CAPACITY FOR BINDING WITH INTRACELLULAR DOMAIN p-55 OF TNF-RECEPTOR, DNA MOLECULE ENCODING THIS POLYPEPTIDE, EXPRESSION VECTOR AND METHOD FOR PREPARING POLYPEPTIDE 1995
  • Vallakh David
  • Boldin Mark
  • Mett Igor'
  • Varfolomeev Evgenij
RU2273664C2
POLYPEPTIDES OF DIRECTED ACTION 2006
  • Rozenbljum Majkl G.
  • Cheung Lorens
  • Liu Mi-Ae
RU2393874C2

RU 2 220 979 C2

Authors

Lajmehn Stjuart D.

Bekmann M. Patritsija

Dates

2004-01-10Published

1994-05-12Filed